INSIGHTS ON CLINICAL TRIAL DESIGN
-
The Expanding Role Of GLP-1 Receptor Agonists In CNS Clinical Research
Metabolic drugs show promise for brain disorders. Emerging evidence suggests they reduce addictive behaviors and may help treat neurodegenerative diseases, opening new pathways for addiction and neurological care.
-
Elosity's Agile RTSM Build Experience
Modern RTSM requires agility. Learn how real-time visibility, flexible configuration, and faster amendments help teams execute studies with greater efficiency.
-
The Implications Of Semaglutide's Connect To Increased Risk Of NAION
Explore the implications of a connection between semaglutide and an increased risk of non-arteritic anterior ischemic optic neuropathy (NAION).
-
Optimizing Movement Disorder Clinical Trials: A Focus On Parkinson's Disease
Join DVCR experts for a presentation on designing effective Parkinson's clinical trials. This webinar covers endpoint selection, patient-centered design, and real-world case studies.
-
Turning Rapid Study Start-Up Into Enrollment Momentum9/18/2026
A large Phase III ATTR-CM outcomes trial spanning 37 countries reached 50% enrollment eight months early, with monthly accrual rates running 3–5x above plan through coordinated cross-functional execution.
-
Patient Support Solutions For Clinical Trials5/14/2025
Learn how Greenphire leverages its more than 17 years of experience to deliver the most flexible and comprehensive patient-focused solutions and services.
-
Linking Neurology And Ophthalmology For Clinical Trials1/22/2025
Learn more about the innovative approach being taken to incorporate ophthalmology into neurology and central nervous system (CNS) research.
-
Five Ways Centralized Trial Finance Improves Site And Patient Satisfaction6/15/2026
Centralizing payments and logistics improves transparency, accelerates reimbursements, and supports better site performance and patient retention in clinical trials.
-
Reassure Patients About Benefits Of Clinical Trial Participation10/29/2025
Gaining a patient’s trust is the first step to trial participation. Find out how to address this in From Cautious to Committed, the first of a three-part webinar series covering strategies across the patient recruitment continuum.
CLINICAL TRIAL DESIGN SOLUTIONS
-
Proof-of-concept provides a critical bridge between Phase 1 and Phase 2 trials, making an experienced CRO partner vital to achieving optimal outcomes for early-phase clinical research.
-
Strengthen trial compliance and data integrity by mastering GCP through practical, real-world scenarios designed to prevent costly errors and ensure audit readiness across your research team.
-
Generate consistent, successful clinical trial recruitment on repeat with Citeline Connect's multifaceted approach to patient engagement and recruitment.
-
CSSi offers unmatched depth and breadth in therapeutic expertise, providing full-spectrum, in-house capabilities, positing the organization as a true end-to-end partner in clinical trials.
-
Altasciences provides deep expertise in all clinical pharmacology studies required for successful regulatory submission across a wide range of therapeutic areas.
View the complete resource library.
Contact an Altasciences expert to learn more about their comprehensive clinical solution.